Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · IEX Real-Time Price · USD
2.550
-0.200 (-7.27%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Ventyx Biosciences Stock Forecast
VTYX's stock price has decreased by -92.92% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Ventyx Biosciences stock have an average target of 18.67, with a low estimate of 2.00 and a high estimate of 62. The average target predicts an increase of 632.16% from the current stock price of 2.55.
Analyst Consensus: Buy
* Price targets were last updated on Jun 13, 2024.
Analyst Ratings
The average analyst rating for VTYX stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 4 | 4 | 4 | 4 | 4 |
| Hold | 6 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | +135.29% | Jun 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +292.16% | Jun 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $6 | Hold | Reiterates | $6 | +135.29% | Jun 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +488.24% | Mar 13, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $12 | Hold → Buy | Upgrades | $12 | +370.59% | Mar 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.41
from -3.30
EPS Next Year
-2.34
from -2.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 350.2M | 707.0M | 1.4B |
| Avg | n/a | n/a | 68.0M | 148.5M | 333.8M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 939.3% | 831.2% |
| Avg | - | - | - | 118.3% | 124.8% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.17 | -1.92 | 0.80 | 4.62 | 9.77 |
| Avg | -2.41 | -2.34 | -1.58 | -0.86 | 0.52 |
| Low | -2.70 | -3.05 | -2.43 | -3.50 | -3.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.